康希诺：mRNA 新冠疫苗已进入临床Ⅱ期试验阶段

Zhitong
2022.09.05 23:23
康希诺近期接受投资者调研时称，公司的 mRNA 新冠疫苗已进入临床Ⅱ期试验阶段，预计今年年底前能够完成大部分的现场工作并收集到初步数据。我们更多的是想通过新冠疫苗这个产品验证我们的 mRNA 平台技术，走通后加速推进其他候选产品的开发，比如带状疱疹、流感等。
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.